Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related deaths and novel treatment approaches are urgently needed. Here we show that poly(ethylene glycol)-functionalized nanodiamonds loaded with doxorubicin (ND-PEG-DOX) afforded a considerable improvement over free drug in an orthotopic pancreatic xenograft model. ND-PEG-DOX complexes were also superior to free DOX in 3-dimensional (3D) tumor spheroids of PDAC. ND-PEG showed no cytotoxicity towards macrophages, and histopathological analysis showed no abnormalities of major organs upon in vivo administration of ND-PEG-DOX. These results provide evidence that ND-mediated drug delivery may serve as a means of improving the therapeutic outcome in PDAC.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 112-121 |
| Number of pages | 10 |
| Journal | Nanomedicine: Nanotechnology, Biology, and Medicine |
| Volume | 18 |
| DOIs | |
| State | Published - Jun 2019 |
Keywords
- Drug delivery
- Nanodiamonds
- Nanomedicine
- Pancreatic adenocarcinoma
ASJC Scopus subject areas
- Bioengineering
- Medicine (miscellaneous)
- Molecular Medicine
- Biomedical Engineering
- General Materials Science
- Pharmaceutical Science
Fingerprint
Dive into the research topics of 'Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS